BNP Paribas Begins Coverage on Church & Dwight (NYSE:CHD)

Equities researchers at BNP Paribas began coverage on shares of Church & Dwight (NYSE:CHD) in a report released on Monday, Briefing.com reports. The brokerage set a “neutral” rating and a $114.00 price target on the stock. BNP Paribas’ price target suggests a potential upside of 4.65% from the stock’s current price.

A number of other brokerages also recently issued reports on CHD. The Goldman Sachs Group started coverage on shares of Church & Dwight in a report on Friday, March 1st. They set a “buy” rating and a $110.00 price target on the stock. HSBC raised their price objective on shares of Church & Dwight from $110.00 to $114.00 and gave the stock a “hold” rating in a report on Friday, May 3rd. Truist Financial raised their price objective on shares of Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Friday, May 3rd. Barclays dropped their price objective on shares of Church & Dwight from $83.00 to $82.00 and set an “underweight” rating on the stock in a report on Monday, May 6th. Finally, Bank of America raised their price objective on shares of Church & Dwight from $100.00 to $104.00 and gave the stock a “neutral” rating in a report on Monday, April 15th. Three investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $106.65.

Church & Dwight Stock Up 0.0 %

Shares of Church & Dwight stock opened at $108.93 on Monday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.33 and a quick ratio of 0.82. The company has a 50-day moving average of $106.62 and a 200 day moving average of $101.62. The firm has a market cap of $26.64 billion, a price-to-earnings ratio of 34.58, a PEG ratio of 3.55 and a beta of 0.51. Church & Dwight has a 1 year low of $82.25 and a 1 year high of $110.31.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.10. Church & Dwight had a net margin of 13.13% and a return on equity of 20.35%. The company had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.49 billion. During the same period last year, the business earned $0.85 EPS. Church & Dwight’s quarterly revenue was up 5.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Church & Dwight will post 3.46 earnings per share for the current fiscal year.

Insider Activity at Church & Dwight

In related news, Director Robert K. Shearer sold 13,200 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $106.36, for a total transaction of $1,403,952.00. Following the sale, the director now owns 29,108 shares of the company’s stock, valued at $3,095,926.88. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Robert K. Shearer sold 13,200 shares of the company’s stock in a transaction on Wednesday, May 8th. The shares were sold at an average price of $106.36, for a total transaction of $1,403,952.00. Following the sale, the director now owns 29,108 shares of the company’s stock, valued at $3,095,926.88. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Maynadier Patrick D. De sold 54,654 shares of the business’s stock in a transaction on Friday, June 14th. The shares were sold at an average price of $107.00, for a total transaction of $5,847,978.00. Following the transaction, the executive vice president now owns 10,325 shares in the company, valued at approximately $1,104,775. The disclosure for this sale can be found here. Insiders have sold a total of 182,346 shares of company stock valued at $19,465,948 over the last 90 days. 2.00% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Game Plan Financial Advisors LLC bought a new position in Church & Dwight during the first quarter valued at $26,000. Crewe Advisors LLC bought a new position in shares of Church & Dwight in the first quarter worth about $28,000. Roble Belko & Company Inc bought a new position in shares of Church & Dwight in the first quarter worth about $31,000. Chilton Capital Management LLC grew its holdings in shares of Church & Dwight by 50.0% in the fourth quarter. Chilton Capital Management LLC now owns 330 shares of the company’s stock worth $31,000 after purchasing an additional 110 shares during the last quarter. Finally, Creekmur Asset Management LLC bought a new position in shares of Church & Dwight in the fourth quarter worth about $32,000. Institutional investors own 86.60% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.